Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/04/2026 ,inter alia, to consider and approve Intimation of Board meeting ....
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has informed the stock exchanges that its Board of Directors will meet on Monday, April 6, 2026. The main item on the agenda is to consider and approve a proposal for buyback of the company's fully paid-up equity shares, along with related matters under the Companies Act, 2013 and SEBI Buyback Regulations, 2018. The trading window for dealing in company securities has been closed for designated persons and their relatives from April 1, 2026 until 48 hours after the declaration of audited financial results for FY ending March 31, 2026. The company will also likely consider its annual audited financial results at or around this meeting.
A potential share buyback is generally viewed positively by investors as it returns surplus cash to shareholders and signals management confidence in the company's valuation. However, key details such as buyback size, price, and mode (tender or open market) are yet to be disclosed and will be decided at the April 6 meeting.